top headlines
Medicus Pharma has submitted an investigational new drug application in [...]
Poolbeg Pharma has presented two posters at the European Hematology [...]
Movers & Shakers
sponsored content
With 89% of AI pilots failing to scale, biopharmas can [...]
Interview with Carol Grassi Mircich, chief commercial marketing and innovation [...]
As Rare Disease Day 2026 highlights the challenges faced by [...]
Other news
Scenic Biotech has joined the Michael J. Fox Foundation’s LRRK2 [...]
Poolbeg Pharma has activated the first clinical site and begun [...]
China’s National Medical Products Administration has approved Shionogi’s Symproic for [...]
Scientists at Scripps Research have developed a new chemical reaction [...]
PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]
OrganaBio has entered a manufacturing partnership with RxMP Therapeutics to [...]
